ICYMI: NEW REPORT DEBUNKS BOGUS BIG PHARMA RHETORIC THAT SOLUTIONS TO LOWER DRUG PRICES WILL CRIMP INNOVATION

02-4-2021 Blog Posts

Study Finds Solutions to Make Medications More Accessible Will Not Restrict R&D and Breakthrough Cures A new report from Patients for Affordable Drugs (P4AD), “Big Pharma’s Big Lie: The Truth About Innovation and Drug Pricing,” debunks Big Pharma’s bogus rhetoric that any action to curb the industry’s price-gouging and anti-competitive tactics will stifle innovation and […]

BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE & ABBVIE

02-4-2021 Blog Posts

Brand Name Pharma Giants Surpass Expectations While Hiking Prices During Pandemic New fourth quarter earnings reports released this week from Big Pharma giants GlaxoSmithKline (GSK) and AbbVie demonstrate yet again that price hikes continue to support expectation-busting profits for brand name drug companies. Both pharmaceutical manufacturers beat Wall Street expectations for the fourth quarter of […]

BIG PHARMA EARNINGS WATCH: PFIZER & AMGEN

02-3-2021 Blog Posts

Big Pharma Giants See Profits Jump After New Year Price Hikes New earnings reports for the fourth quarter of 2020 show that Big Pharma giants are continuing to rake in big profits while hiking prescription drug prices during the pandemic. On Tuesday, Pfizer and Amgen announced earnings for the fourth quarter of 2020 that bested […]

BIG PHARMA EARNINGS WATCH: ELI LILLY

01-29-2021 Blog Posts

Brand Name Drug Company Sees Soaring Profits After Hiking Prices Today, brand name drug giant Eli Lilly announced rising profits for the fourth quarter of 2020 – topping analysts’ expectations. The company clocked $7.44 billion in revenue for Q4 – surpassing analysts’ expectations. Stock for Eli Lilly surged to a ‘record high’ driven by strong […]

ICYMI: STUDY FINDS U.S. BRAND NAME DRUG PRICES “SIGNIFICANTLY HIGHER” THAN THOSE IN OTHER COUNTRIES

01-28-2021 Blog Posts

New RAND Report Finds Rx Prices in U.S. Average 3.44 Times Higher Than Those in 32 Other Countries In case you missed it, a new report from the RAND Corporation finds that prescription drug prices in the United States average a whopping 3.44 times higher than those seen in 32 other countries. According to Andrew […]

PRESCRIPTION FOR CHANGE: WHY DRUG PRICES ARE OUT-OF-CONTROL AND HOW TO FIX IT

01-28-2021 Blog Posts

CSRxP Briefing Covers Impact of Affordability Crisis, Drug Company’s Price-Hiking Practices and Bipartisan, Market-Based Solutions The Campaign for Sustainable Rx Pricing (CSRxP) hosted a briefing, “Prescription for Change: Why Drug Prices Are Out-of-Control and How to Fix It,” on Wednesday. CSRxP was joined for the briefing by a panel of leaders representing hospitals, physicians, health […]

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON & NOVARTIS

01-27-2021 Blog Posts

Price Hikes Fuel Sky-High Earnings For Brand Name Giants As millions of Americans continue to grapple with the economic impact of the COVD-19 pandemic, the first earnings reports for the fourth quarter of 2020 from Big Pharma demonstrate that hiking prices on American patients continues to be a profitable practice for the industry. Yesterday, brand […]

BIG PHARMA WATCH: NEW STUDY FINDS DRUG COMPANIES CONTINUING TO HIKE PRICES WITHOUT IMPROVING THEIR DRUGS

01-13-2021 Blog Posts

Unjustified Rx Price Increases Cost American Patients & Health System Billions Big Pharma repeatedly hikes prices on brand name drugs without making any improvements to those medications. That’s the finding of a new analysis conducted by the Institute for Clinical and Economic Review (ICER). The report found that drug companies hiked prices on seven popular […]

BIG PHARMA WATCH: HEADLINES FROM BIG PHARMA’S NEW YEAR PRICE HIKES

01-11-2021 Blog Posts

Second Major Round of Pandemic Price Increases Underscores Urgency for Congress to Hold Drug Companies Accountable In case you missed it, Big Pharma hiked prices on at least 629 prescription drugs in just the first week of the New Year. Brand name giants Pfizer, GlaxoSmithKline and Sanofi were among the companies who increased prices on […]

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

12-31-2020 Blog Posts

Part IV: Escalating Assault on 340B Program for Providers Serving America’s Most Vulnerable Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now, the ongoing economic impact of the public health crisis continues to leave millions of American workers, families and seniors struggling just to stay afloat. Meanwhile, prescription […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.